PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Promethazine teoclate - Vestibular disorders
PAD Profile : Promethazine teoclate - Vestibular disorders
Keywords :
nausea and vomiting, vertigo, labyrinthine disorders, motion sickness
Traffic Light Status
Status 1 of 1.
Status :
Green
Important
Formulations :
- Oral solution
- Tablets
Important Information :
This is a lower cost promethazine option for primary care but note difference in recommended doses between teoclate and hydrochloride salts
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Cinnarizine
- Cyclizine hydrochloride
- Prochlorperazine maleate
- Hyoscine hydrobromide
- Promethazine hydrochloride
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo